Table 1.
Year | Investigator | Method | #P/#. C | % | HPV type |
---|---|---|---|---|---|
1992 | Kellokoski et al.29 | PCR | 18/78 | (23) | 6, 11 e 16(83%), 18(17%) |
SB | 33/212 | (15) | 2,6,11,13,16,18 | ||
1992 | Jalal et al.27 | PCR | 21 /48 | (44) | 16 |
1993 | Holladay and Gerald. 25 | PCR | 1/6 | (17) | 16 |
1995 | Eike et al.16 | PCR | 0/61 | 0 | - |
1995 | Mao et al. 34 | PCR | 4/26 | (15) | 16 |
1996 | Tominaga et al. 76 | PCR | 3/3 | (100) | 6 |
SB | 0/3 | 0 | - | ||
1996 | Cruz et al. 11 | PCR | 0/12 | 0 | - |
1996 | Mao et al. 35 | PCR | 0/6 | 0 | - |
1998 | D’Costa et al. 12 | PCR | 15/48 | (31) | 16 |
1998 | Badaracco et al. 4 | PCR | 4/22 | (18) | 6(20%), 16(50%), 31, 11(10%) |
1999a | Terai et al. 72 | PCR | 26/30 | (87) | 18(87%), 61(60%), 59(23%), 16(7%) |
1999 | Pillai et al. 51 | ISH | 0/10 | 0 | - |
1999 | Bustos et al.8 | ISH | 0/33 | 0 | - |
2003 | Surgyama et al. 64 | PCR | 16/44 | (36) | 16 |
#= number; P = positives; C = cases; ISH =in situ hybridization; SB = Southern blot hybridization; PCR = polymerase chain reaction.